Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of reviews and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of pediatric conditions; and the practical management of specific clinical situations.
Pediatric Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.
Journal information
- Editor
-
- Rod McNab
- Publishing model
- Hybrid. Learn about publishing Open Access with us
Journal metrics
- 2.519 (2019)
- Impact factor
- 2.329 (2019)
- Five year impact factor
- 30 days
- Submission to first decision
- 130 days
- Submission to acceptance
- 82,065 (2019)
- Downloads
Latest issue
Latest articles
-
-
-
-
Clinical and Economic Evaluation of the Impact of Midazolam on Morphine Therapy for Pain Relief in Critically Ill Ventilated Infants with Respiratory Distress Syndrome
Authors (first, second and last of 5)
-
Paediatric Agranulocytosis Associated with Metamizole Treatment
Authors (first, second and last of 6)
About this journal
- Electronic ISSN
- 1179-2019
- Print ISSN
- 1174-5878
- Abstracted and indexed in
-
- CNKI
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Academic Search
- EBSCO Advanced Placement Source
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information